Walk into a clinic with a Class IV laser and you’ll hear a version of this: “Red light therapy is fine, but our laser is more powerful — it penetrates deeper and actually reaches your injury.” It’s a compelling pitch. It’s also more marketing than settled science. Both technologies are doing fundamentally the same thing to your cells, and the research comparing them is a lot murkier than the sales sheet suggests. Here’s what actually differs, and what each one is genuinely better for.
We use red light therapy at Kinetix, and we’re going to be straight with you about its strengths and its limits — including the cases where a different tool fits better. That honesty is the point of this whole article.
First: They’re the Same Fundamental Mechanism
This is the part the “more powerful” pitch skips. Red light therapy (RLT) and Class IV laser therapy are both forms of photobiomodulation (PBM) — the use of specific wavelengths of red and near-infrared light to drive cellular processes. The mechanism is identical at the cell: light is absorbed by an enzyme in your mitochondria called cytochrome c oxidase, which boosts ATP (cellular energy) production, modulates oxidative stress, and influences inflammatory signaling.[1]
Class IV laser isn’t a different kind of therapy from red light. It’s the same therapy delivered by a more powerful, more focused device. That distinction matters, because it reframes the real question. It’s not “laser or light?” It’s “how much power, at what wavelength, delivered to what depth — and does more of it actually help?”
The Coherence Myth (This Is the Big One)
The central selling point for laser over LED is coherence — the property that makes laser light a tight, focused, in-phase beam versus the scattered light of an LED. The claim is that coherence lets laser penetrate deeper and work better. For decades this was treated as obvious. The research has largely dismantled it.
Tiina Karu — one of the founders of photobiomodulation science — ran experiments directly comparing coherent (laser) and non-coherent (LED) light with wavelength, power density, and dose matched. The finding: cellular responses were equivalent. Coherence is lost within roughly the first 100–200 micrometers of tissue as light scatters — so by the time photons reach their target deeper down, laser and LED light are equally scattered anyway. The 2018 consensus paper on PBM nomenclature (Anders et al.) put it plainly: the same biological effects can be achieved with coherent and non-coherent sources when equivalent parameters are used.[2]
What drives the effect isn’t the beam.
It’s the wavelength, the dose, and the depth.
So if coherence isn’t the magic ingredient, is there any real physical difference between the two? Yes — but it’s not the one the marketing leads with.
What Actually Differs: Power, Depth, and Heat
The genuine differences come down to power output and what that power does.
Red Light Therapy (LED)
Low power · milliwatts/cm² · non-coherent
- Broad coverage over large areas at once
- No thermal effect — cool to the skin
- Very high safety margin; no eye-protection burden for typical use
- Can be used frequently, longer sessions, even at home
- Best absorbed in superficial-to-moderate tissue (skin, superficial muscle)
- Lower cost per session
Class IV Laser (HILT)
High power · watts/cm² · coherent, focused
- Concentrated beam targets a small, specific area
- Delivers a given dose faster — shorter per-point time
- Adds a photothermal (heating) effect on top of PBM
- Higher power can push more photons toward deep targets
- Requires a trained operator and eye protection
- Higher equipment and treatment cost
The Depth Question — Real, but Nuanced
Higher power and longer near-infrared wavelengths (Class IV systems often use 1064 nm) do reach deeper tissue more effectively. One ex-vivo study found 1064 nm light penetrated the upper 10 mm of tissue better than shorter wavelengths.[3] For a genuinely deep target — a hip joint, a lumbar structure, a deep tendon — getting an adequate dose to that depth is a real consideration, and raw power helps. But note the logic: what matters is dose delivered at depth. Power is a means to that end, not the goal itself.
The Thermal Effect — a Different Mechanism
Here’s a distinction that rarely gets made honestly. Class IV lasers generate meaningful heat — enough that skin temperature management is part of the clinical literature.[4] That photothermal effect can be therapeutic (increasing circulation, tissue extensibility, and pain-gating), but it’s a different mechanism than the photochemical PBM effect both devices share. So part of Class IV’s clinical effect isn’t “more photobiomodulation” — it’s added heat. That’s not a knock; it’s just not the story you’re usually told. It also means some of what a Class IV laser does, a hot pack plus RLT could partly approximate.
So What Does the Head-to-Head Research Show?
This is where the marketing narrative and the peer-reviewed evidence part ways. If Class IV were dramatically superior for musculoskeletal conditions, the comparative trials would show it clearly. They don’t.
A systematic review of 12 studies across 704 participants — covering tennis elbow, carpal tunnel, chronic low back pain, knee arthritis, plantar fasciitis, and shoulder impingement — found no statistically significant difference between high-intensity (Class IV) and low-level laser therapy for pain, disability, or quality of life. Each edged the other on isolated secondary measures (low-level was better for grip strength; high-intensity for certain tissue-imaging parameters), but on the outcomes that matter most, they were comparable.[5]
A 2026 systematic review and network meta-analysis reached a similar place: high-intensity laser showed modestly greater pain reduction than low-level therapy in some comparisons — but the effects were generally small and rated at very low certainty of evidence.[6]
Sources: High-intensity vs low-level laser systematic review (704 participants); de la Barra Ortiz et al., Lasers in Medical Science 2026 network meta-analysis.Two honest caveats cut in both directions. First, most of this head-to-head research compares two lasers (low-level/Class III vs high-intensity/Class IV) — not LED red-light panels against Class IV directly, which is a thinner literature. Second, the certainty of evidence across this whole area is low, meaning future studies could shift the picture. What the current evidence does not support is the confident claim that Class IV is broadly, clearly superior for musculoskeletal pain.
What Each Is Actually Better For
Strip away the sales pitch and the practical picture is genuinely useful — because they have different sweet spots.
| Consideration | Red Light Therapy (LED) | Class IV Laser |
|---|---|---|
| Broad muscle groups | Strong fit — covers wide areas | Inefficient — small beam |
| Deep, focal targets | Limited by penetration | Strong fit — power + focus |
| Superficial tissue & recovery | Strong fit | Overkill for the task |
| Treatment speed per point | Slower | Faster |
| Safety / frequency of use | Very high — frequent use easy | Requires precautions |
| Cost | Lower | Higher |
In plain terms: red light therapy is well-suited to broad-area recovery, superficial-to-moderate tissue, and frequent, low-risk use. A Class IV laser has a real edge when the target is deep and focal and you want to deliver a dose quickly in a clinical setting. Neither is a scam; neither is a miracle. They’re tools with different geometries.
The Lesson That Actually Matters
If you take one thing from this: the device category matters far less than whether the treatment delivers the right wavelength and an adequate dose to the tissue you’re actually trying to affect. A well-dosed LED treatment can outperform a poorly-dosed laser session, and vice versa. “Class IV” on the label tells you about power — it doesn’t tell you whether the protocol is right for your problem.
And this connects to a bigger truth we’ve written about before: every light-based modality, laser or LED, is an adjunct — not the treatment. Photobiomodulation has real but supporting evidence in musculoskeletal care. It works best layered onto the things that do the heavy lifting: accurate assessment, manual therapy, and progressive loading. Any clinic selling a laser as the centerpiece of your recovery has the priorities backwards.
We use RLT as an evidence-based adjunct — for supporting recovery and superficial-to-moderate tissue, layered into a treatment plan built on assessment, ART, and corrective exercise. We’re honest about where it helps and where it doesn’t, and we’re not going to sell you a modality as a cure. If your presentation genuinely called for something RLT can’t reach, we’d tell you that too. That’s the difference between using a tool and marketing one.
The Bottom Line
Red light therapy and Class IV laser are the same underlying therapy — photobiomodulation — delivered at different power levels. The “coherence makes laser better” claim doesn’t survive contact with the research. The head-to-head evidence shows modest, mixed, low-certainty differences, not a clear winner. Class IV has a real edge for deep, focal targets and speed; RLT has real advantages in coverage, safety, frequency, and cost. And both are adjuncts to the care that actually drives recovery.
Don’t choose a clinic by the wattage of its laser. Choose it by whether they can tell you honestly what any given tool will and won’t do for your specific problem.
Curious Whether Red Light Therapy Fits Your Recovery?
We use it where the evidence supports it — as part of a complete, assessment-first plan, not a standalone miracle. Learn more about our approach, or book a visit and we’ll tell you honestly what will actually move your recovery forward.
Book an Assessment ?References
- Reviews of photobiomodulation mechanisms describing light absorption by cytochrome c oxidase, mitochondrial activation, ATP synthesis, and modulation of oxidative stress and inflammation — the shared mechanism of LED and laser PBM. Review of light parameters and photobiomodulation efficacy, 2021. PMC
- Karu TI, comparative experiments on coherent vs non-coherent light at matched parameters; Anders JJ, et al. Low-level light/laser therapy versus photobiomodulation therapy (2018 nomenclature consensus). Lasers in Surgery and Medicine. (Equivalent biological effects from coherent and non-coherent sources at equivalent parameters; coherence lost to scattering in superficial tissue.)
- Penetration depth comparison of 905 nm and 1064 nm laser light in biological tissue ex vivo. 2023. (1064 nm penetrated the upper 10 mm of tissue better than shorter wavelengths.) PMC
- Chaki C, De Taboada L, Tse KM. Comparative analysis of pulsed and continuous wave modes in high-intensity laser light therapy: implications for deep tissue treatment. Journal of Biophotonics. 2025. (Documents skin-temperature/thermal considerations and 1064 nm deep-tissue fluence in Class IV laser delivery.) PMC
- High-intensity versus low-level laser therapy in musculoskeletal disorders: systematic review (12 studies, 704 participants). (No statistically significant difference in pain, disability, or quality of life; divergent results on isolated secondary measures.) PMC
- de la Barra Ortiz HA, Parizotto N, Liebano RE. Comparison of the effectiveness of high-intensity laser therapy versus low-level laser therapy in musculoskeletal disorders: a systematic review and network meta-analysis. Lasers in Medical Science. 2026. (HILT modestly greater pain reduction in some comparisons; effects small, very low certainty of evidence.) PMC
This article is for general educational purposes and does not constitute medical advice. Photobiomodulation is best used as one component of a comprehensive, individualized treatment plan.
